Thymoquinone Modulates Local MMP-9, IL-10, and IgG in Sciatic Nerve Crush Injury Animal Model

Valentinus Besin, Abdul Hafid Bajamal, I Ketut Sudiana, Mangestuti Agil, Jusak Nugraha, Mohammad Hasan Machfoed, Paulus Budiono Notopuro, Naesilla Naesilla

Abstract


BACKGROUND: Interleukin (IL)-10 is involved in Wallerian degeneration after peripheral nerve crush injury. Oral thymoquinone was previously observed to decrease local immunoglobulin-G (IgG) in a crush-injured rat model. No study has evaluated the pathway of various thymoquinone dosages on local IgG and IL-10 in this injury.

METHODS: This experimental study used 126 Rattus norvegicus Wistar rats that were divided into 18 groups: six groups received a placebo, the other six groups received thymoquinone at 100 mg/kg/day and the last six groups received thymoquinone at 250 mg/kg/day, respectively. Rats were sacrificed at 12, 18, 24, 5x24, 6x24, and 7x24 hours. Matrix metalloproteinase-9 (MMP-9), IL-10, and local IgG levels were assessed by Enzyme-Linked Immunosorbent Assay (ELISA). The nuclear factor KappaB (NF-κB) expressions on Schwann cells were examined by flow cytometry. Path analysis was performed using SmartPLS.

RESULTS: The path analysis showed that 100mg/kg/day of thymoquinone significantly decreased NF-κB expression. However, NF-κB did not affect local MMP-9, and MMP-9 had no significant relationship with local IL-10 and IgG. Thymoquinone 250 mg/kg/day also significantly inhibited NF-kB expression, decreased local MMP-9, and, in turn, decreased local IL-10 and IgG.

CONCLUSION:  Administration of oral thymoquinone 250 mg/kg/day decreases local IgG and IL-10 levels via suppressing NF-κB expression and MMP-9 levels.

KEYWORDS: thymoquinone, crush injury, IgG, IL-10, MMP-9, NF-κB


Full Text:

PDF

References


Menorca RMG, Fussell TS, Elfar JC. Peripheral nerve trauma: mechanisms of injury and recovery. Hand Clin. 2013; 29(3): 317-30, CrossRef.

Belkas JS, Shoichet MS, Midha R. Peripheral nerve regeneration through guidance tubes. Neurol Res. 2004; 26(2): 151-60, CrossRef.

Issack PS, Helfet DL. Sciatic nerve injury associated with acetabular fractures. HSS Journal. 2009; 5(1): 12-8, CrossRef.

Immerman I, Price AE, Alfonso I, Grossman JAI. Lower extremity nerve trauma. Bull Hosp Joint Dis. 2014; 72(1): 43-52, PMID.

Hussain G, Wang J, Rasul A, Anwar H, Qasim M, Zafar S, et al. Current status of therapeutic approaches against peripheral nerve injuries: A detailed story from injury to recovery. Int J Biol Sci. 2020; 16(1): 116-34, CrossRef.

Portincasa A, Gozzo G, Parisi D, Annacontini L, Campanale A, Basso G, et al. Microsurgical treatment of injury to peripheral nerves in upper and lower limbs: A critical review of the last 8 years. Microsurgery. 2007; 27(5): 455-62, CrossRef.

Noble J, Munro CA, Prasad VSSV, Midha R. Analysis of upper and lower extremity peripheral nerve injuries in a population of patients with multiple injuries. J Trauma. 1998; 45(1): 116-22, CrossRef.

Alvites R, Rita Caseiro A, Santos Pedrosa S, Vieira Branquinho M, Ronchi G, Geuna S, et al. Peripheral nerve injury and axonotmesis: State of the art and recent advances. Cogent Medicine. 2018; 5(1): 1-45, CrossRef.

Rotshenker S. Wallerian degeneration: the innate-immune response to traumatic nerve injury. J Neuroinflammation. 2011; 8: 109, CrossRef.

DeFrancesco-Lisowitz A, Lindborg JA, Niemi JP, Zigmond RE. The neuroimmunology of degeneration and regeneration in the peripheral nervous system. Neuroscience. 2015; 302: 174-203, CrossRef.

Chen YM, Shen RW, Zhang B, Zhang WN. Regional tissue immune responses after sciatic nerve injury in rats. Int J Clin Exp Med. 2015; 8(8): 13408-12, PMID.

Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol. 2008; 180(9): 5771-7, CrossRef.

Meiliana A, Wijaya A. Macrophage polarization in metabolism and metabolic disease. Indones Biomed J. 2013; 5(2): 81-90, CrossRef.

Nurdianto AR, Arwati H, Dachlan YP, Febiyanti DA. The relationship of hemoglobin, interleukin-10 and tumor necrosis factor alpha levels in asymptomatic malaria patients in Trenggalek, Jawa Timur, Indonesia. Mol Cell Biomed Sci. 2019; 3(1): 13-6, CrossRef.

Farkhondeh T, Samarghandian S, Shahri AMP, Samini F. The neuroprotective effects of thymoquinone: A review. Dose-Response. 2018; 16(2): 1-11, CrossRef.

Sidharta BRA, Purwanto B, Wasita B, Widyaningsih V, Soetrisno S. Single or divided administration of cisplatin can induce inflammation and oxidative stress in male Sprague-Dawley rats. Indones Biomed J. 2022; 14(2): 164-71, CrossRef.

Araújo-Filho HG, Quintans-Júnior LJ, Barreto AS, Almeida JRGS, Barreto RSS, Quintans JSS. Neuroprotective effect of natural products on peripheral nerve degeneration: a systematic review. Neurochem Res. 2016; 41(4): 647-58, CrossRef.

Sereflican M, Yurttas V, Ozyalvacli G, Terzi EH, Turkoglu SA, Yildiz S, et al. The histopathological and electrophysiological effects of thymoquinone and methylprednisolone in a rabbit traumatic facial nerve paralysis model. Am J Otolaryngol. 2016; 37(5): 407-15, CrossRef.

Besin V, Bajamal AH, Machfoed MH, Nugraha J, Utomo B, Notopuro PB. The effect of thymoquinone administration on local immunoglobulin-G levels of Rattus norvegicus strain wistar sciatic nerve crush injury model. Indones Biomed J. 2022; 14(1): 91-7, CrossRef.

Çelik F, Göçmez C, Karaman H, Kamaşak K, Kaplan I, Akil E, et al. Therapeutic effects of thymoquinone in a model of neuropathic pain. Curr Ther Res Clin Exp. 2014; 76: 11-6, CrossRef.

Bauder AR, Ferguson TA. Reproducible mouse sciatic nerve crush and subsequent assessment of regeneration by whole mount muscle analysis. J Vis Exp. 2012; (60): 3606, CrossRef.

Ogden M, Karaca SB, Aydin G, Yuksel U, Dagli AT, Akkaya S, et al. The healing effects of thymoquinone and dexpanthenol in sciatic nerve compression injury in rats. J Invest Surg. 2021; 34(5): 504-12, CrossRef.

Bala U, Tan KL, Ling KH, Cheah PS. Harvesting the maximum length of sciatic nerve from adult mice: A step-by-step approach. BMC Res Notes. 2014; 7(1): 714, CrossRef.

Elabscience. Rat MMP-9 (Matrix Metalloproteinase 9) ELISA Kit. Wuhan: Elabscience; 2022.

Chattopadhyay S, Myers RR, Janes J, Shubayev V. Cytokine regulation of MMP-9 in peripheral glia: Implications for pathological processes and pain in injured nerve. Brain Behav Immun. 2007; 21(5): 561-8, CrossRef.

Mokarram N, Merchant A, Mukhatyar V, Patel G, Bellamkonda R v. Effect of modulating macrophage phenotype on peripheral nerve repair. Biomaterials. 2012; 33(34): 8793-801, CrossRef.

Hossen MJ, Yang WS, Kim D, Aravinthan A, Kim JH, Cho JY. Thymoquinone: An IRAK1 inhibitor with in vivo and in vitro anti-inflammatory activities. Sci Rep. 2017; 7: 42995, CrossRef.

Sethi G, Ahn KS, Aggarwal BB. Targeting nuclear factor-κB activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res. 2008; 6(6): 1059-70, CrossRef.

Morton PD, Johnstone JT, Ramos AY, Liebl DJ, Bunge MB, Bethea JR. Nuclear factor-κB activation in Schwann cells regulates regeneration and remyelination. Glia. 2012; 60(4): 639-50, CrossRef.

Chattopadhyay S, Shubayev VI. MMP-9 controls Schwann cell proliferation and phenotypic remodeling via IGF-1 and ErbB receptor-mediated activation of MEK/ERK pathway. Glia. 2009; 57(12): 1316-25, CrossRef.

Arumugam P, Subramanian R, Priyadharsini JV, Gopalswamy J. Thymoquinone inhibits the migration of mouse neuroblastoma (Neuro-2a) cells by down-regulating MMP-2 and MMP-9. Chin J Nat Med. 2016; 14(12): 904-12, CrossRef.

Zhu N, Xiang Y, Zhao X, Cai C, Chen H, Jiang W, et al. Thymoquinone suppresses platelet-derived growth factor-BB–induced vascular smooth muscle cell proliferation, migration and neointimal formation. J Cell Mol Med. 2019; 23(12): 8482-92, CrossRef.

Arif M, Thakur SC, Datta K. Implication of thymoquinone as a remedy for polycystic ovary in rat. Pharm Biol. 2016; 54(4): 674-85, CrossRef.

Akhtari M, Zargar SJ, Vojdanian M, Jamshidi A, Mahmoudi M. Monocyte-derived and M1 macrophages from ankylosing spondylitis patients released higher TNF-α and expressed more IL1B in response to BzATP than macrophages from healthy subjects. Sci Rep. 2021; 11(1): 17842, CrossRef.

Hong H, Gao M, Wu Q, Yang P, Liu S, Li H, et al. IL-23 promotes a coordinated B cell germinal center program for class-switch recombination to IgG2b in BXD2 mice. J Immunol. 2020; 205(2): 346-58, CrossRef.

Vargas ME, Barres BA. Why is Wallerian degeneration in the CNS so slow? Annu Rev Neurosci. 2007; 30: 153-79, CrossRef.

Febriza A, Ridwan R, As’ad S, Kasim VN, Idrus HH. Adiponectin and its role in inflammatory process of obesity. Mol Cell Biomed Sci. 2019; 3(2): 60-6, CrossRef.

Yanik BM, Dauch JR, Cheng HT. Interleukin-10 reduces neurogenic inflammation and pain behavior in a mouse model of type 2 diabetes. J Pain Res. 2020; 13: 3499-512, CrossRef.

Mietto BS, Kroner A, Girolami EI, Santos-Nogueira E, Zhang J, David S. Role of IL-10 in resolution of inflammation and functional recovery after peripheral nerve injury. J Neurosci. 2015; 35(50): 16431-42, CrossRef.

Khan J, Ramadan K, Korczeniewska O, Anwer MM, Benoliel R, Eliav E. Interleukin-10 levels in rat models of nerve damage and neuropathic pain. Neurosci Lett. 2015; 592: 99-106, CrossRef.




DOI: https://doi.org/10.18585/inabj.v14i3.2011

 

Indexed by:

                  

               

                 

 

 

The Prodia Education and Research Institute